Announcements Trials

Browse Landscape

Phase

Status

Unknown 1 Recruiting 1 Not yet recruiting 1 Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Polycystic Ovary Syndrome 1 Insulin Resistance 1

Interventions

Cyclophosphamide 956 Radiotherapy 847 Cisplatin 757 Gemcitabine 657 Carboplatin 603 Docetaxel 598 Paclitaxel 585 Bevacizumab 580 Fluorouracil 504 Oxaliplatin 458 Rituximab 453 Surveys and Questionnaires 449 Capecitabine 440 Dexamethasone 428 Doxorubicin 424 Etoposide 411 Irinotecan 389 Cytarabine 376 Filgrastim 369 pembrolizumab 330 Leucovorin 305 Nivolumab 296 fludarabine phosphate 294 Melphalan 288 Magnetic Resonance Spectroscopy 281 Peripheral Blood Stem Cell Transplantation 279 Blood Specimen Collection 279 Methotrexate 276 Lenalidomide 276 Cetuximab 270

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × OTHER × Canagliflozin × Clear all

NCT04700839 2022-09-10

PCOS

Shanghai 10th People's Hospital

Phase 4 Completed

Insulin Resistance, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡